These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 24557576)
1. Outcomes of liver transplantation for porto-pulmonary hypertension in model for end-stage liver disease era. Salgia RJ; Goodrich NP; Simpson H; Merion RM; Sharma P Dig Dis Sci; 2014 Aug; 59(8):1976-82. PubMed ID: 24557576 [TBL] [Abstract][Full Text] [Related]
2. Comparison of Post-Liver Transplantation Outcomes in Portopulmonary Hypertension and Pulmonary Venous Hypertension: A Single-Center Experience. Rajaram P; Parekh A; Fisher M; Kempker J; Subramanian R Transplant Proc; 2017 Mar; 49(2):338-343. PubMed ID: 28219595 [TBL] [Abstract][Full Text] [Related]
3. Mending the Model for End-Stage Liver Disease: An in-depth review of the past, present, and future portopulmonary hypertension Model for End-Stage Liver Disease exception. DuBrock HM; Del Valle KT; Krowka MJ Liver Transpl; 2022 Jul; 28(7):1224-1230. PubMed ID: 35106916 [TBL] [Abstract][Full Text] [Related]
4. Pulmonary Vascular Resistance Predicts Mortality and Graft Failure in Transplantation Patients With Portopulmonary Hypertension. Jose A; Shah SA; Anwar N; Jones CR; Sherman KE; Elwing JM Liver Transpl; 2021 Dec; 27(12):1811-1823. PubMed ID: 33964116 [TBL] [Abstract][Full Text] [Related]
5. Portopulmonary hypertension: Still an appropriate consideration for liver transplantation? Verma S; Hand F; Armstrong MJ; de Vos M; Thorburn D; Pan T; Klinck J; Westbrook RH; Auzinger G; Bathgate A; Masson S; Holt A; Houlihan DD; Ferguson JW Liver Transpl; 2016 Dec; 22(12):1637-1642. PubMed ID: 27593213 [TBL] [Abstract][Full Text] [Related]
8. Pulmonary contraindications, indications and MELD exceptions for liver transplantation: a contemporary view and look forward. Krowka MJ; Wiesner RH; Heimbach JK J Hepatol; 2013 Aug; 59(2):367-74. PubMed ID: 23557870 [TBL] [Abstract][Full Text] [Related]
9. Liver Transplantation for Hepatitis B in Early Adulthood: Analysis of the United Network for Organ Sharing Database. Rifai G; Anani A; Hanouneh IA; Mohamad B; Matloob A; Lopez R; Zein NN; Alkhouri N Transplant Proc; 2016 Dec; 48(10):3362-3367. PubMed ID: 27931582 [TBL] [Abstract][Full Text] [Related]
10. Outcomes among older adult liver transplantation recipients in the model of end stage liver disease (MELD) era. Malinis MF; Chen S; Allore HG; Quagliarello VJ Ann Transplant; 2014 Sep; 19():478-87. PubMed ID: 25256592 [TBL] [Abstract][Full Text] [Related]
12. "Porto-pulmonary hypertension: a comprehensive review". Liberal R; Grant CR; Baptista R; Macedo G Clin Res Hepatol Gastroenterol; 2015 Apr; 39(2):157-67. PubMed ID: 25659878 [TBL] [Abstract][Full Text] [Related]
13. Liver Transplantation for Hepatic Epithelioid Hemangioendothelioma Is Facilitated by Exception Points With Acceptable Long-term Outcomes. Brahmbhatt M; Prenner S; Bittermann T Transplantation; 2020 Jun; 104(6):1187-1192. PubMed ID: 31577674 [TBL] [Abstract][Full Text] [Related]
14. Portopulmonary hypertension in the current era of pulmonary hypertension management. Savale L; Guimas M; Ebstein N; Fertin M; Jevnikar M; Renard S; Horeau-Langlard D; Tromeur C; Chabanne C; Prevot G; Chaouat A; Moceri P; Artaud-Macari É; Degano B; Tresorier R; Boissin C; Bouvaist H; Simon AC; Riou M; Favrolt N; Palat S; Bourlier D; Magro P; Cottin V; Bergot E; Lamblin N; Jaïs X; Coilly A; Durand F; Francoz C; Conti F; Hervé P; Simonneau G; Montani D; Duclos-Vallée JC; Samuel D; Humbert M; De Groote P; Sitbon O J Hepatol; 2020 Jul; 73(1):130-139. PubMed ID: 32145258 [TBL] [Abstract][Full Text] [Related]